Abnormal sympathetic signaling through adrenergic receptors is a major cause for many cardiovascular diseases, including heart failure, which is one of the leading health problems around the world. Sympathetic control is mediated mainly through norepinephrine, which signals via adrenergic receptors present on the surface of cardiac cells. Consistent with this, drugs targeting the adrenergic signaling pathway have been the mainstay for managing cardiovascular diseases and cardiac failure for many years. Adrenergic receptor activation initiates important regulatory events that cause their removal from the cell surface, which reduces cellular sensitivity to sympathetic stimuli. A critical sortin step in the endosome, which either recycles receptors back to the cell surface or directs them to be degraded, then decides whether and how fast cells recover their sensitivity. Recent evidence suggests that the sorting of receptors to specialized domains on the endosome that mediate recycling also allow receptors to interact with specialized signaling complexes and initiate signaling pathways with discrete functions. Research using prototypical G protein-coupled receptors (GPCRs) like the beta 2-adrenergic receptor (B2AR), has established that GPCRs require specific sequences on their C-termini, as well as a set of proteins that interact with thes sequences, to enter this pathway and recycle. Disrupting these interactions redirects B2AR to the lysosome. Why this is so, considering that many other proteins can recycle via a bulk recycling pathway without any apparent requirements, is a fundamental question that has not been answered. This proposal addresses how B2AR is excluded from the bulk recycling pathway, and why this is important in adrenergic signaling. The experiments test the hypothesis that specific endosomal machinery actively excludes B2AR from the bulk recycling pathway, and that this exclusion regulates the bias of B2AR signaling from the endosome vs. the plasma membrane. The approach taken is to first identify the machinery that excludes B2AR from the bulk pathway, and then disrupt it to determine the consequences on signaling. A better understanding of the mechanisms that regulate adrenergic receptor recycling will provide a platform for developing new therapeutic strategies against heart failure by identifying potential entry points for intervention. Further, as B2AR is a prototypical member of the G protein-coupled receptor family of signaling receptors, whose members show strong structural and functional similarities, the techniques developed and the principles identified will be broadly applicable to other members of this clinically relevant family of signaling receptors.

Public Health Relevance

Abnormal sympathetic signaling through adrenergic receptors forms the root cause for many cardiovascular disorders, and it is a leading cause for heart failure. Therefore, understanding the physiological mechanisms that regulate adrenergic receptor function will broadly improve our understanding of the cellular processes underlying the development of heart failure, and provide a platform for designing better therapeutic strategies towards combating this major health problem.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
7R01GM117425-03
Application #
9745234
Study Section
Molecular and Integrative Signal Transduction Study Section (MIST)
Program Officer
Koduri, Sailaja
Project Start
2016-02-01
Project End
2020-12-31
Budget Start
2017-07-01
Budget End
2017-12-31
Support Year
3
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Weinberg, Zara Y; Puthenveedu, Manojkumar A (2018) Regulation of G protein-coupled receptor signaling by plasma membrane organization and endocytosis. Traffic :
Boyd-Shiwarski, Cary R; Shiwarski, Daniel J; Roy, Ankita et al. (2018) Potassium-regulated distal tubule WNK bodies are kidney-specific WNK1 dependent. Mol Biol Cell 29:499-509
Thomas, Marcus; Schwartz, Russell (2017) Quantitative computational models of molecular self-assembly in systems biology. Phys Biol 14:035003
Shiwarski, Daniel J; Darr, Marlena; Telmer, Cheryl A et al. (2017) PI3K class II ? regulates ?-opioid receptor export from the trans-Golgi network. Mol Biol Cell 28:2202-2219
Weinberg, Zara Y; Zajac, Amanda S; Phan, Tiffany et al. (2017) Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the ยต Opioid Receptor. Mol Pharmacol 91:416-427
Shiwarski, Daniel J; Tipton, Alycia; Giraldo, Melissa D et al. (2017) A PTEN-Regulated Checkpoint Controls Surface Delivery of ? Opioid Receptors. J Neurosci 37:3741-3752
Gokhale, Avanti; Hartwig, Cortnie; Freeman, Amanda H et al. (2016) The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse. J Neurosci 36:12393-12411
Bowman, Shanna Lynn; Shiwarski, Daniel John; Puthenveedu, Manojkumar A (2016) Distinct G protein-coupled receptor recycling pathways allow spatial control of downstream G protein signaling. J Cell Biol 214:797-806
McGarvey, Jennifer C; Xiao, Kunhong; Bowman, Shanna L et al. (2016) Actin-Sorting Nexin 27 (SNX27)-Retromer Complex Mediates Rapid Parathyroid Hormone Receptor Recycling. J Biol Chem 291:10986-1002
Tian, Xufan; Irannejad, Roshanak; Bowman, Shanna L et al. (2016) The ?-Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the ?2-Adrenergic Receptor. J Biol Chem 291:14510-25